Verona Pharma PLC

Biotechnology • Healthcare • London, United Kingdom • VRNA (NGM)

Verona Pharma plc, a biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company offers Ohtuvayre, a dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that combines bronchodilator and non-steroidal anti-inflammatory effects for the maintenance treatment of chronic obstructive pulmonary disease, as well as cystic fibrosis and asthma. Verona Pharma plc was formerly known as Isis Resources plc and changed its name to Verona Pharma plc in September 2006. The company was incorporated in 2005 and is based in London, the United Kingdom. As of October 7, 2025, Verona Pharma plc operates as a subsidiary of Merck Sharp & Dohme LLC.

Stock Performance

Stock price data not yet populated

Symbol: VRNA

Layoff History

No layoff events recorded for this company.

Recent News

VERONA PHARMA Q4 2025 Earnings Preview: Recent $VRNA Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative

Quiver Quantitative • Jan 3

Verona Pharma plc (VRNA) Nears $10B Merck Buyout, Ohtuvayre Boosts COPD Portfolio - Yahoo Finance

Yahoo Finance • Sep 30

Merck completes acquisition of Verona Pharma; VRNA shares delisted from Nasdaq - Investing.com

Investing.com • Oct 7

Merck to acquire Verona Pharma - 07:00:08 09 Jul 2025 - RTW News article - London Stock Exchange

London Stock Exchange • Jul 9

$10 Billion Respiratory Disease Deal: Merck to Acquire Verona Pharma After 99.5% Shareholder Approval - Stock Titan

Stock Titan • Sep 24

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Verona Pharma plc had layoffs?

No layoff events have been recorded for Verona Pharma plc in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Verona Pharma plc have?

Verona Pharma plc has approximately 209 employees.

What industry is Verona Pharma plc in?

Verona Pharma plc operates in the Biotechnology industry, within the Healthcare sector.

Is Verona Pharma plc a publicly traded company?

Yes, Verona Pharma plc is publicly traded under the ticker symbol VRNA on the NGM. The company has a market capitalization of approximately $9.09 billion.

Where is Verona Pharma plc headquartered?

Verona Pharma plc is headquartered in London, United Kingdom.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.